EDVA Endovia Health Sciences, Inc.
Beverages · NYSE · SEC CIK 1553788 · Fiscal year ends 12/31
Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY79.3%
TTM net income YoY33.3%
TTM EPS YoY89.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin-13.6%
Operating margin3,741.9%
Net margin4,787.7%
FCF margin—
EBITDA margin3,756.9%
Returns
ROE—
ROA-148.3%
ROIC (approx.)—
Asset turnover-0.03x
Leverage & solvency
Liabilities / assets1,563.2%
Debt / equity—
Current ratio0.05x
Interest coverage-5.67x
Cash quality & payout
Operating cash flow / net income0.31x
Accruals ratio-101.6%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $73,066 | $801,273 | $18.85M | $18.09M | $11.32M |
| Cost of revenue | — | $3.80M | $13.28M | $12.17M | $7.40M |
| Gross profit | $16,898 | -$119,797 | $5.57M | $5.92M | $3.92M |
| Operating income | -$14.19M | -$9.90M | -$15.29M | -$21.39M | -$29.08M |
| Interest expense | $2.52M | $3.70M | $1.86M | $251,497 | $442,807 |
| Income tax | $0 | $0 | $0 | $0 | $0 |
| Net income | -$25.23M | -$23.76M | -$21.00M | -$21.69M | -$29.05M |
| EBITDA | -$14.18M | -$9.50M | -$14.74M | -$20.46M | -$28.97M |
| EPS (basic) | -11.97 | -17.68 | — | — | -1.02 |
| EPS (diluted) | -11.97 | -17.68 | — | — | -1.02 |
| Weighted avg. shares (diluted) | 2.18M | 1.34M | 1.06M | 37.39M | 28.90M |
| Banking | |||||
| Net interest income | -$2.52M | -$3.70M | -$1.85M | — | -$442,807 |
| Balance sheet | |||||
| Cash & equivalents | $281,435 | $15,346 | $167,168 | $4.43M | $4.18M |
| Receivables | $15,748 | $191,991 | $890,631 | $1.81M | $1.11M |
| Inventory | $33,538 | $319,104 | $2.25M | $3.72M | $1.92M |
| Current assets | $631,993 | $1.90M | $3.98M | $10.66M | $8.34M |
| PP&E, net | $12,926 | $22,210 | $349,802 | $489,597 | $569,785 |
| Goodwill | — | — | $256,823 | $256,823 | $256,823 |
| Intangibles | — | — | $4.46M | $4.85M | $5.60M |
| Total assets | $965,694 | $2.76M | $9.90M | $17.30M | $16.39M |
| Current liabilities | $16.26M | $19.37M | $14.75M | $4.97M | $6.48M |
| Long-term debt | $3,418 | $1.97M | $457,656 | $2.54M | $0 |
| Total debt | $3,418 | $1.97M | $457,656 | $2.54M | $0 |
| Total liabilities | $16.27M | $21.39M | $15.50M | $7.98M | $7.51M |
| Shareholders' equity | -$15.30M | -$18.63M | -$5.61M | $9.32M | $8.87M |
| Net debt | -$278,017 | $1.96M | $290,488 | -$1.90M | -$4.18M |
| Shares outstanding | 749,450 | 1.67M | 1.11M | 41.09M | 33.60M |
| Cash flow statement | |||||
| Operating cash flow | -$4.82M | -$7.30M | -$10.19M | -$14.04M | -$14.70M |
| Capital expenditure | — | $3,235 | $14,113 | $102,698 | $0 |
| Free cash flow | — | -$7.31M | -$10.20M | -$14.14M | -$14.70M |
| Investing cash flow | — | -$3,235 | -$14,113 | -$102,698 | $0 |
| Financing cash flow | $5.10M | $7.54M | $6.15M | $14.45M | $19.01M |
| Depreciation & amortization | $9,284 | $401,602 | $545,977 | $936,020 | $111,567 |
| Stock-based compensation | $8.62M | $2.36M | $1.17M | $7.41M | $3.97M |
Free plan shows the latest 5 periods; Pro shows all 15 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.